Investors considering a purchase of Ardelyx Inc (Symbol: ARDX) stock, but cautious about paying the going market price of $4.87/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is
Ardelyx is a California-based biopharmaceutical firm that develops and commercializes minimally-systemic therapeutics for the treatment of cardiorenal and gastrointestinal diseases.